Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Human Vaccines & Immunotherapeutics|January 10, 2019
Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine liveDesmond Curran, Brandon J Patterson, Desiree Van Oorschot, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|July 1, 2021
Estimated Public Health Impact of the Recombinant Zoster VaccineBrandon J Patterson, Philip O Buck, Desmond Curran, et al.
The Journal of Dermatological Treatment|July 1, 2020
Cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe psoriasis in the United StatesXiaoying Jia, Yang Zhao, Justin Carrico, et al.
Pharmacoeconomics|March 6, 2026
Public Health Impact and Cost-Effectiveness of Revising the Adolescent Meningococcal Vaccine Schedule in the United StatesOscar Herrera-Restrepo, Ginita Jutlla, Jonathan Graham, et al.
Pediatrics|July 13, 2022
Impact of Routine Childhood Immunization in Reducing Vaccine-Preventable Diseases in the United StatesSandra E Talbird, Justin Carrico, Elizabeth M La, et al.
Human Vaccines & Immunotherapeutics|March 7, 2023
Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancerDesmond Curran, Brandon J Patterson, Justin Carrico, et al.
Expert Review of Vaccines|October 7, 2024
Public health impact and return on investment of the pediatric National Immunization Program in ItalyMarco Barbieri, Sandra E Talbird, Justin Carrico, et al.
Expert Review of Vaccines|September 22, 2025
The public health and economic impact of the Greek pediatric national immunization programIlias Gountas, Sandra E Talbird, Justin Carrico, et al.
Pageof 4